Abstract
The transcription factor »signal transducer and activator of transcription 5b« (STAT5b) is associated with tumor growth and metastases in various cancer entities (e.g. breast and prostate cancer). Activation of this transcription factor via cytokines (e. g. IL-6), growth factors (e. g. EGF) and oncogenes (e. g. src) promotes growth and motility of tumor cells. Therefore, we sought to determine the expression of STAT5b in human pancreatic adenocarcinoma (HPAC) and investigate the effects of selective STAT5b blockade on tumor growth and motility of pancreatic cancer cell lines. Using immunohistochemistry, expression of nuclear STAT5b was determined in HPAC tissue samples. In vitro, selective inhibition of STAT5b was achieved using stable transfection of human pancreatic cancer cell lines (HPAF-II, L3.6pl, BxPC-3) with STAT5b shRNA plasmid (SureSilencing, Super Array, SA Bioscience). Knock-down of STAT5b was determined using Western Blot. In vitro, the effect of STAT5b blockade on growth of tumor cells was investigated by MTT assays whereas changes in motility were evaluated in Boyden chamber assays. A subcutaneous tumor model was used to determine effects of STAT5b blockade on tumor growth in vivo. Our results show that nuclear expression of STAT5b can be found in 28/31 HPAC tissue samples. In vitro, STAT5b blockade had no effect on growth of tumor cells whereas tumor cell motility was significantly impaired (P < 0.05). The subcutaneous tumor model showed that knock-down of STAT5b leads to significant inhibition of tumor growth (P < 0.05) that was also reflected by final tumor weight (P < 0.05). In summary, STAT5b is expressed in HPAC. Blockade of STAT5b impairs tumor cell motility in vitro and tumor growth in vivo. Hence, STAT5b might be an interesting target for anti-neoplastic therapy in HPAC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Levy DE, Darnell JE Jr (2002 )Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651–662
Tan SH, Nevalainen MT (2008) Signal transducer and activator of transcription 5A/B in prostate and breast cancers. Endocr Relat Cancer 15: 367–390
Yu H, Jove R (2004) The STATs of cancer – new molecular targets come of age. Nat Rev Cancer 4: 97–105
Lee TK, Man K, Poon RT et al. (2006) Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res 66: 9948–9956
Riggins RB, Thomas KS, Ta HQ et al. (2006) Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res 66: 7007–7015
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lang, S. et al. (2010). STAT5b als neues »Target« für anti-neoplastische Therapiekonzepte beim humanen Pankreaskarzinom. In: Gradinger, R., Menger, M., Meyer, HJ. (eds) Chirurgisches Forum und DGAV Forum 2010. Deutsche Gesellschaft für Chirurgie, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12192-0_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-12192-0_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12191-3
Online ISBN: 978-3-642-12192-0
eBook Packages: Medicine (German Language)